Report cover image

Global Lipid Nanoparticle (LNP) Services Market Growth (Status and Outlook) 2025-2031

Published Aug 15, 2025
Length 144 Pages
SKU # LPI20314211

Description

The global Lipid Nanoparticle (LNP) Services market size is predicted to grow from US$ 4079 million in 2025 to US$ 5591 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.

Lipid Nanoparticle (LNP) Services involve the development, production, and related technical support of lipid nanoparticles used in the pharmaceutical and biomedical fields. LNPs are stable nanoparticles composed of functional lipids, pegylated lipids, saturated phospholipids, and cholesterol. LNP Services aim to provide customized solutions for clients, covering the whole process from the early-stage research and development to large-scale production.

United States market for Lipid Nanoparticle (LNP) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Lipid Nanoparticle (LNP) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Lipid Nanoparticle (LNP) Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Lipid Nanoparticle (LNP) Services players cover PreciGenome, Creative Biolabs, GenScript, ReciBioPharm, CD Bioparticles, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Lipid Nanoparticle (LNP) Services Industry Forecast” looks at past sales and reviews total world Lipid Nanoparticle (LNP) Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Lipid Nanoparticle (LNP) Services sales for 2025 through 2031. With Lipid Nanoparticle (LNP) Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lipid Nanoparticle (LNP) Services industry.

This Insight Report provides a comprehensive analysis of the global Lipid Nanoparticle (LNP) Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lipid Nanoparticle (LNP) Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lipid Nanoparticle (LNP) Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lipid Nanoparticle (LNP) Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lipid Nanoparticle (LNP) Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Lipid Nanoparticle (LNP) Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
Formulation Service
Development Service
Others

Segmentation by Application:
Drug Delivery
Diagnostics
Gene Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PreciGenome
Creative Biolabs
GenScript
ReciBioPharm
CD Bioparticles
Vernal Biosciences
Hzymes Biotech
LipExoGen
Evonik Vancouver Laboratories
Merck
Cayman
Echelon
WuXi STA
BOC Sciences
Carcell
Cambridge Bioscience
FluidicLab
Guangzhou Anernor Biotechnology
Nanjing Yasmin Biotechnology
vectorbuilder
Helix Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

144 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Lipid Nanoparticle (LNP) Services Market Size by Player
4 Lipid Nanoparticle (LNP) Services by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Lipid Nanoparticle (LNP) Services Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.